Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà
MedNavigator.ru - Ïîèñê è ïîäáîð ëå÷åíèÿ â Ðîññèè è çà ðóáåæîì

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Èíôåêöèîííûå áîëåçíè > Ãåïàòèòû

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #16  
Ñòàðûé 06.10.2016, 21:17
Àâàòàð äëÿ easl
easl easl âíå ôîðóìà
Âðà÷-èíôåêöèîíèñò
      
 
Ðåãèñòðàöèÿ: 05.02.2008
Ãîðîä: Áàêó
Ñîîáùåíèé: 18,445
Ïîáëàãîäàðèëè 5,215 ðàç(à) çà 4,965 ñîîáùåíèé
easl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ôèáðîýëàñòîìåòðèÿ (Ôèáðîñêàí).
__________________
Ñ óâàæåíèåì, Þñèô Àëõàçîâ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #17  
Ñòàðûé 27.05.2017, 16:18
wakecg wakecg âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 02.08.2015
Ãîðîä: Ïåðìü
Ñîîáùåíèé: 49
Ñêàçàë(à) ñïàñèáî: 5
wakecg *
Þñèô Ìóñàåâè÷ , äîáðûé äåíü!

Íåäàâíî ïðîõîäèë ìðò âñåãî ïîçâîíî÷íèêà ïî ïîâîäó áîëåé â ñïèíå, òàì ïîïàëè â êàäð âñå îðãàíû,íàçðåë âîïðîñ:

1)Ìîæíî ëè îöåíèòü ñîñòîÿíèå ïå÷åíè ïî òàêîìó ìðò? Ïî ññûëêå Ïðîãðàììû íå íóæíî óñòàíàâëèâàòü [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

2)Åñëè õðîíè÷åñêèé ãåïàòèò ïðîãðåññèðóåò äîëæåí ëè ÷åëîâåê áîëåòü ÎÐÇ ÷àùå èëè íå îáÿçàòåëüíî? Óæå îêîëî ãîäà íå áîëåë (÷òî íà ìåíÿ íå î÷åíü ïîõîæå) íî ïîñòîÿííî óñòàëîñòü è êëîíèò â ñîí åñëè äàæå ñïëþ 10 ÷àñîâ.È åùå ïîñòîÿííî õî÷åòñÿ êóøàòü, åñëè íå åì æåëóäîê áóðëèò
3) Íóæíî ëè ñëåäèòü çà DNA HBV (êîëè÷.) ?
4) Åñòü ëè ñìûñë äåëàòü ÌÐÒ ïå÷åíè êðîìå ôèáðîñêàíà?
Áîëåé â ðàéîíå ïå÷åíè íåòó,òåìïåðàòóðû íåòó,Àíàëèçû ÎÀÊ âðîäå â íîðìå,ïðèêðåïèë.
Ôèáðîñêàí ïîêà ðåçóëüòàòîâ íåò,íå ñäåëàë , ïëàíèðóþ íà ñëåä. íåäåëå
Âëîæåíèÿ
Òèï ôàéëà: pdf Kostarev (1).pdf (143.5 Êá, 15 ïðîñìîòðîâ)
Òèï ôàéëà: pdf Kostarev.pdf (155.3 Êá, 15 ïðîñìîòðîâ)
Îòâåòèòü ñ öèòèðîâàíèåì
  #18  
Ñòàðûé 29.05.2017, 13:21
Àâàòàð äëÿ easl
easl easl âíå ôîðóìà
Âðà÷-èíôåêöèîíèñò
      
 
Ðåãèñòðàöèÿ: 05.02.2008
Ãîðîä: Áàêó
Ñîîáùåíèé: 18,445
Ïîáëàãîäàðèëè 5,215 ðàç(à) çà 4,965 ñîîáùåíèé
easl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
1. Ýòî âîïðîñ ê ðàäèîëîãó, à íå êî ìíå.
2. Íå äîëæåí.
3. Íóæíî.
4. Äîñòàòî÷íî ÓÇÈ äëÿ íà÷àëà.
__________________
Ñ óâàæåíèåì, Þñèô Àëõàçîâ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #19  
Ñòàðûé 29.05.2017, 19:12
wakecg wakecg âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 02.08.2015
Ãîðîä: Ïåðìü
Ñîîáùåíèé: 49
Ñêàçàë(à) ñïàñèáî: 5
wakecg *
Óçè+Ýëàñòîìåòðèÿ. Âðîäå âñå â íîðìå?
HBV DNA ðàç â 6 ìåñ ñäàâàòü âìåñòå ñ àëò?
Ìèíèàòþðû
Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: DSC_0154.JPG
Ïðîñìîòðîâ: 48
Ðàçìåð:	1.49 Ìá
ID:	130129  Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: DSC_0155.JPG
Ïðîñìîòðîâ: 56
Ðàçìåð:	1.32 Ìá
ID:	130130  Íàæìèòå íà èçîáðàæåíèå äëÿ óâåëè÷åíèÿ
Íàçâàíèå: DSC_0156.JPG
Ïðîñìîòðîâ: 55
Ðàçìåð:	1.29 Ìá
ID:	130131  
Îòâåòèòü ñ öèòèðîâàíèåì
  #20  
Ñòàðûé 30.05.2017, 21:26
Àâàòàð äëÿ easl
easl easl âíå ôîðóìà
Âðà÷-èíôåêöèîíèñò
      
 
Ðåãèñòðàöèÿ: 05.02.2008
Ãîðîä: Áàêó
Ñîîáùåíèé: 18,445
Ïîáëàãîäàðèëè 5,215 ðàç(à) çà 4,965 ñîîáùåíèé
easl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ýòî íå ýëàñòîìåòðèÿ, à ýëàñòîãðàôèÿ.
Èæåâñêèå ðàäèîëîãè íàñòîëüêî ñóðîâû, ÷òî ó íèõ öèððîç íà÷èíàåòñÿ îò 20 êÏà?
Âî âñåì ìèðå èíà÷å - êàê ìàêñèìóì îò 12.5, âîîáùå-òî.
__________________
Ñ óâàæåíèåì, Þñèô Àëõàçîâ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #21  
Ñòàðûé 30.05.2017, 22:56
wakecg wakecg âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 02.08.2015
Ãîðîä: Ïåðìü
Ñîîáùåíèé: 49
Ñêàçàë(à) ñïàñèáî: 5
wakecg *
Þñèô,äîáðûé âå÷åð!
Íå çíàþ íà ñêîëüêî îíè ñóðîâû íî ïîñìîòðåë íà ïàáìåä òàì â ðàçíûõ èññëåäîâàíèÿõ òå æå öèôðû è äàæå 24êÏà
2016
Evaluation of liver fibrosis

The median delay between ARFI and TE in the 46 evaluated patients was 10 days (range, 0–25 days). Median liver stiffness on TE was 6.1 kPa (range 3.4–35.3 kPa) and median shear wave velocity (SWV) on ARFI was 1.29 m/s (range 0.93–2.86 m/s). Median liver stiffnesses on TE in patients with F1, F2, F3, and F4 fibrosis stages were 5.4 kPa (range 4.1–6.1 kPa), 7.2 kPa (range, 7.1–7.8 kPa), 11.6 kPa (range, 10.8–12.3 kPa) and 24.6 kPa (range, 18.0–27.7 kPa), respectively.

Íî åñëè ñìîòðåòü ïî ýòèì äàííûì òî ó ìåíÿ ïîëó÷àåòñÿ ô1.Âîçìîæíî îò àïïàðàòà ê àïïàðàòó çíà÷åíèÿ ìåíÿþòñÿ â çàâèñèìîñòè îò ìåòîäà. Ïî ïîâîäó ýëàñòîãðàôèè ,ìíå ñêàçàëè ÷òî ýòî òîæå ñàìîå ÷òî è ýëàñòîìåòðèÿ ,íî èññëåäîâàíèå áûëî óêàçàíî êàê ýëàñòîìåòðèÿ. Åùå ñêàçàëè ÷òî ó íàñ â ÐÔ ôèáðîñêàí 502 áîëüøå íå áóäóò çàêóïàòü ò.ê àïïàðàòû Àèêñïëîðåð è Ñèìåíñ ïîêàçàëè ëó÷øèå ðåçóëüòàòû ïî îöåíêå ôèáðîçîâ,òàê æå óêàçàë ÷òî ó ôèáðîñêàí 502 íóæíî êàëèáðîâàòü äàò÷èê êàæäûé ìåñÿö à ýòèì çàíèìàþòñÿ òîëüêî â ñòîëèöå,ñ íàøåé ìåäèöèíîé åãî âîçìîæíî âîîáùå íèêòî íå êàëèáðóåò íî ðåçóëüòàòû â ñðàâíåíèè ñ 2013ãîäîì ïî÷òè òå æå,òîãäà áûëî 5.3êïà íà Ôèáðîñêàí 502.
Îòâåòèòü ñ öèòèðîâàíèåì
  #22  
Ñòàðûé 30.05.2017, 22:58
wakecg wakecg âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 02.08.2015
Ãîðîä: Ïåðìü
Ñîîáùåíèé: 49
Ñêàçàë(à) ñïàñèáî: 5
wakecg *
Ñêàæèòå ïîæàëóéñòà, ó âàñ åñòü äàííûå î òîì ÷òî àïïàðàòû siemens acuson s2000 è Aixplorer âûäàþò íåäîñòîâåðíûå äàííûå? Õîòåëîñü áû îçíàêîìèòüñÿ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #23  
Ñòàðûé 02.06.2017, 17:58
Àâàòàð äëÿ easl
easl easl âíå ôîðóìà
Âðà÷-èíôåêöèîíèñò
      
 
Ðåãèñòðàöèÿ: 05.02.2008
Ãîðîä: Áàêó
Ñîîáùåíèé: 18,445
Ïîáëàãîäàðèëè 5,215 ðàç(à) çà 4,965 ñîîáùåíèé
easl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íà Fibroscan-502 äàò÷èêè êàëèáðóþñÿ 1 ðàç â 6 ìåñÿöåâ.

Öèòàòà:
Consensus statements
• TE is an established technique and is recommended as
the initial assessment for significant liver fibrosis and
cirrhosis (A1).
• TE helps to predict complications of cirrhosis and its
prognosis (A2).
• The interpretation of results should be carefully
weighted in the presence of limiting factors (A1).
• TE is a highly reproducible and user-friendly technique
for assessing liver fibrosis in patients with CLD.
However, because TE reproducibility is significantly
reduced (p\0.05) in patients with steatosis, increased
BMI, lower degrees of hepatic fibrosis and narrow
intercostal spaces, caution could be warranted in the
clinical use of TE as surrogate for LB (A1).
• SSI is an accurate measure in predicting fibrosis stage
and is as accurate as TE and ARFI in this respect (B2).
Asian-Pacific Association for the Study of the Liver (APASL)
consensus guidelines on invasive and non-invasive assessment
of hepatic fibrosis: a 2016 update
Hepatol Int (2017) 11:1–30
__________________
Ñ óâàæåíèåì, Þñèô Àëõàçîâ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #24  
Ñòàðûé 27.02.2018, 12:52
wakecg wakecg âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 02.08.2015
Ãîðîä: Ïåðìü
Ñîîáùåíèé: 49
Ñêàçàë(à) ñïàñèáî: 5
wakecg *
Þñèô Ìóñàåâè÷ , Çäðàâñòâóéòå!
Ñêàæèòå ïîæàëóéñòà, íóæíî ëè ìíå ñäàâàòü àíàëèç DNA HBV (êîëè÷.) ðàç â ïîë ãîäà\ãîä ?
Ó íàñ ìîæíî ñäàòü åùå HBsAg (ÈÔÀ) èëè HBsAg (ÈÕËÀ) ñóïåð
Íà äàííûé ìîìåíò äåëàþ òîëüêî Áèîõèìèþ,îáùèé àíàëèç,óçè,ôèáðîñêàí.
Íà äàííûé ìîìåíò ïîÿâèëèñü ðåäêèå áîëè ñïðàâà ïîä ðåáðîì è ïîâûøåííîå ñëþíîîòäåëåíèå ïîñëå åäû è âîîáùå â òå÷åíèè äíÿ.Ñâÿçûâàþ ýòî ñ ïîâûøåíîé êèñëîòíîñòüþ ò.ê ðåäêî áûâàëà êèñëàÿ îòðûæêà\÷óâñòâî êîìà â ãðóäè\ãîðëå ïîñëå åäû è â òå÷åíèè äíÿ. Ñòàë ïðèíèìàòü Îìåïðàçîë âðîäå ïîëó÷øå.Çàâòðà ïîéäó ñäàâàòü àíàëèçû. Ìîæíî \íóæíî ëè ïðèíèìàòü ñåé÷àñ óðñîôàëüê ñ îìåïðàçîëîì?Åñëè äà â êàêîé äîçèðîâêå
Îòâåòèòü ñ öèòèðîâàíèåì
  #25  
Ñòàðûé 27.02.2018, 13:42
Àâàòàð äëÿ easl
easl easl âíå ôîðóìà
Âðà÷-èíôåêöèîíèñò
      
 
Ðåãèñòðàöèÿ: 05.02.2008
Ãîðîä: Áàêó
Ñîîáùåíèé: 18,445
Ïîáëàãîäàðèëè 5,215 ðàç(à) çà 4,965 ñîîáùåíèé
easl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò wakecg Ïîñìîòðåòü ñîîáùåíèå
Ñêàæèòå ïîæàëóéñòà, íóæíî ëè ìíå ñäàâàòü àíàëèç DNA HBV (êîëè÷.) ðàç â ïîë ãîäà\ãîä ?..
Ðàç â ïîëãîäà.
__________________
Ñ óâàæåíèåì, Þñèô Àëõàçîâ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #26  
Ñòàðûé 05.03.2018, 19:14
wakecg wakecg âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 02.08.2015
Ãîðîä: Ïåðìü
Ñîîáùåíèé: 49
Ñêàçàë(à) ñïàñèáî: 5
wakecg *
Öèòàòà:
Ñîîáùåíèå îò easl Ïîñìîòðåòü ñîîáùåíèå
Ðàç â ïîëãîäà.
DNA HBV 12 000 êîïèé\ìë èíñòðóìåíò CFX96
âñÿ áèîõèìèÿ â íîðìå,òîëüêî êàëèé 5.5

Ìîíèòîðèíã?
Îòâåòèòü ñ öèòèðîâàíèåì
  #27  
Ñòàðûé 06.03.2018, 11:33
Àâàòàð äëÿ easl
easl easl âíå ôîðóìà
Âðà÷-èíôåêöèîíèñò
      
 
Ðåãèñòðàöèÿ: 05.02.2008
Ãîðîä: Áàêó
Ñîîáùåíèé: 18,445
Ïîáëàãîäàðèëè 5,215 ðàç(à) çà 4,965 ñîîáùåíèé
easl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Êîíòðîëü ÷åðåç 3 ìåñÿöà.
__________________
Ñ óâàæåíèåì, Þñèô Àëõàçîâ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #28  
Ñòàðûé 06.03.2018, 19:32
wakecg wakecg âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 02.08.2015
Ãîðîä: Ïåðìü
Ñîîáùåíèé: 49
Ñêàçàë(à) ñïàñèáî: 5
wakecg *
Þñèô Ìóñàåâè÷ , äîáðûé äåíü!
×åðåç 3 ìåñ ïîâòîðèòü âèðóñíóþ íàãðóçêó òîëüêî èëè:
âèðóñíóþ íàãðóçêó
ÀËÒ
ÀÑÒ
Áèëèðóáèí
ÔÈáðîñêàí\óçè
?
Îòâåòèòü ñ öèòèðîâàíèåì
  #29  
Ñòàðûé 07.03.2018, 10:24
Àâàòàð äëÿ easl
easl easl âíå ôîðóìà
Âðà÷-èíôåêöèîíèñò
      
 
Ðåãèñòðàöèÿ: 05.02.2008
Ãîðîä: Áàêó
Ñîîáùåíèé: 18,445
Ïîáëàãîäàðèëè 5,215 ðàç(à) çà 4,965 ñîîáùåíèé
easl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåeasl ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Áèëèðóáèí, ÀËÒ, ÀÑÒ, âèðóñíóþ íàãðóçêó, ôèáðîýëàñòîìåòðèþ è ÓÇÈ.
__________________
Ñ óâàæåíèåì, Þñèô Àëõàçîâ.
Îòâåòèòü ñ öèòèðîâàíèåì
  #30  
Ñòàðûé 26.12.2018, 11:08
wakecg wakecg âíå ôîðóìà Ïîë ìóæñêîé
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 02.08.2015
Ãîðîä: Ïåðìü
Ñîîáùåíèé: 49
Ñêàçàë(à) ñïàñèáî: 5
wakecg *
Þñèô Ìóñàåâè÷, äîáðûé äåíü.

Ïîäåëèòåñü ïîæàëóéñòà ñâîèì ìíåíèåì.

Ñ îêòÿáðÿ çàáîëåë òåìïåðàòóðà áûëà 38-38-38-39 äàëåå íà÷àë ïèòü ñóìàìåä. Âîîáùåì ëå÷èëñÿ ìåñÿö ,ïåðåáîëåë 3 ðàçà ïî êðóãó.âðîäå êàê îòïóñòèëî íî ñïóñòÿ íåäåëþ îïÿòü çàáîëåë è ïî ñåé äåíü ïðîäîëæàþ áîëåòü. ìîìåíò áîëåçíè ñäàë àíàëèç íà ãåðïåñ âèðóñû.

Âèðóñ Ýïøòåéí áàð Ïöð êðîâè îáíàðóæåí 97êîïèé\ìë
igm ê êàïñèäó îòðèöàòåëüíî.
igg ê êàïñèäó 20 ïðè íîðìå äî 1
àëò íîðìà
àñò íîðìà
áèëèðóáèí 30 -íà ôîíå àíòèáèîòèêà âîçìîæíî

Íà äàííûé ìîìåíò ÿ ïðîäîëæàþ áîëåòü,ñèëüíàÿ óñòàëîñòü,ðàçáèòîñòü,òðåìîð â ñîñòîÿíèè ïîêîÿ.Áûë ó ëîðà ñêàçàë åé ïðî ÂÝÁ, îíà ñêàçàëà ÷òî îí âûçûâàåò âòîðè÷íûé èìóíîäåôèöèò,ïðîïèñàëà Íåîâèð â óêîëàõ+áóäîñòåð êðàñíîå ãîðëî è íå äûøèò íîñà (áåç ñîïëåé).Ê èíôåêöèîíèñòó íå ìîãó ïîïàñòü,ìíîãèå âðà÷è óøëè íà ïðàçäíèêè äî 9 ÷èñëà.
×òî äåëàòü ñ âýá , åñòü ñìûñë ïèòü ôàìâèð,èçîïðåíîçèí?
Áóäîñòåð âî âðåìÿ ÂÝÁ èíôåêöèè åñòü ðèñêè?

Òàê æå ñäàâàë ÿ èìóíîãðàììó âî âðåìÿ áîëåçíè â êîòîðîé áûë ñíèæå ôàãîöèòîç 57 ïðè íîðìå îò 60
Ôàãîöèòàðíûé èíäåêñ 1.51 ïðè íîðìå îò 3
Ïðîøó ñîâåòà.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 09:35.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.